Notably, over 50% of T-ALL patients harbor gain-of-function mutations in the NOTCH1 gene, which encodes the receptor for DLL4, while around 10% of patients exhibit similar mutations in the IL-7 receptor (IL7R) gene (Liu et al., 2017). Here, IL7R is linked to acute lymphoblastic leukemia.